ProQR Therapeutics BV Cash Flow-to-Debt Ratio
ProQR Therapeutics BV cash flow-to-debt ratio. ProQR Therapeutics BV (PRQR) has a Cash Flow-to-Debt Ratio of -0.23x as of June 2026, meaning its operating cash flow of $-12.40 Million could theoretically repay 0% of its total liabilities ($54.05 Million) in one year. Check ProQR Therapeutics BV cash earnings quality to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of ProQR Therapeutics BV (2013–2025)
Cash flow-to-debt ratio of ProQR Therapeutics BV from 2013 to 2025. Historical debt coverage capacity for ProQR Therapeutics BV across 13 annual periods. Check ProQR Therapeutics BV total reinvestment intensity to assess the company's total reinvestment commitment from operating cash flow.
ProQR Therapeutics BV Cash Flow-to-Debt Ratio by Year (2013–2025)
ProQR Therapeutics BV cash flow-to-debt ratio by year from 2013 to 2025. Year-by-year debt coverage analysis for ProQR Therapeutics BV. For the full cash flow conversion analysis, see cash efficiency ratio of ProQR Therapeutics BV.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.71x | $-52.79 Million | $74.44 Million | ▼ -60.2% |
| 2024 | -0.44x | $-36.39 Million | $82.22 Million | ▼ -319.0% |
| 2023 | 0.20x | $21.55 Million | $106.59 Million | ▲ +133.0% |
| 2022 | -0.61x | $-68.51 Million | $111.68 Million | ▼ -158.4% |
| 2021 | -0.24x | $-26.01 Million | $109.57 Million | ▲ +74.0% |
| 2020 | -0.91x | $-47.06 Million | $51.61 Million | ▲ +44.8% |
| 2019 | -1.65x | $-43.97 Million | $26.61 Million | ▲ +5.5% |
| 2018 | -1.75x | $-30.68 Million | $17.55 Million | ▲ +17.2% |
| 2017 | -2.11x | $-34.95 Million | $16.54 Million | ▲ +19.2% |
| 2016 | -2.62x | $-34.22 Million | $13.09 Million | ▼ -20.9% |
| 2015 | -2.16x | $-24.23 Million | $11.20 Million | ▼ -5.8% |
| 2014 | -2.04x | $-14.46 Million | $7.07 Million | ▼ -454.9% |
| 2013 | -0.37x | $-2.33 Million | $6.33 Million | — |